Literature DB >> 7647339

Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma.

G Dran1, I A Luthy, A A Molinolo, F Montecchia, E H Charreau, C D Pasqualini, C Lanari.   

Abstract

The effect of progesterone (Pg), medroxyprogesterone acetate (MPA), estradiol (E2), dihydrotestosterone (DHT) and dexamethasone (DEXA) was studied on the in vitro growth rate of a progestin-dependent (PD), estrogen-sensitive mammary tumor line originated in an MPA-treated BALB/c mouse (C4-HD), and on its estrogen-resistant variant (C4-HDR). The specificity of hormone action was further investigated using the anti-hormones RU-486 and hydroxyflutamide (FLU). Cell growth was evaluated in epithelial and fibroblast-enriched cultures using 3H-thymidine and/or autoradiography and immunocytochemistry. The results indicate that cell growth is directly stimulated by MPA and Pg at concentrations ranging from 10(-11) to 10(-7) M. RU486 prevented MPA-induced stimulation in concentrations 10 to 100 fold lower than those of MPA. When used alone, it inhibited cell proliferation only in concentrations higher than 10(-11) M. At nM concentrations, neither DEXA nor DHT stimulated 3H-thymidine uptake except DEXA at 100 nM. MPA-induced stimulation was not reverted by micromolar concentrations of FLU. As for E2 (10(-7)-10(-9) M) it prevented MPA stimulation only in cultures of estrogen-sensitive tumors. Progesterone receptors (PR) (475 +/- 115 fmoles/10(5) cells, n = 5) and estrogen receptors (ER) (ND-115 fmoles/10(5) cells, n = 5) were detected only in epithelial-enriched cultures. Serum from 7 day-MPA-treated mice induced a significant increase of 3H-thymidine uptake; an increase was also obtained with serum from untreated ovariectomized animals to which 1 nM-100 nM concentrations of MPA had been added. The stimulatory effect of the exogenous MPA was much lower than that of the serum obtained from MPA-treated animals. It is concluded that MPA stimulates cell growth of primary cultures of MPA-induced PD tumors via PR. The results provide support for a direct effect of MPA which may be mediated or potentiated by serum factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647339     DOI: 10.1007/bf00668207

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  40 in total

Review 1.  Progestin regulation of cellular proliferation.

Authors:  C L Clarke; R L Sutherland
Journal:  Endocr Rev       Date:  1990-05       Impact factor: 19.871

Review 2.  Mechanisms of growth control in normal and malignant breast epithelium.

Authors:  M E Lippman; R B Dickson
Journal:  Recent Prog Horm Res       Date:  1989

Review 3.  Growth factors and cancer.

Authors:  A S Goustin; E B Leof; G D Shipley; H L Moses
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

4.  Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice.

Authors:  C Lanari; A A Molinolo; C D Pasqualini
Journal:  Cancer Lett       Date:  1986-11       Impact factor: 8.679

5.  Effect of hormones and epidermal growth factor on the growth of the hormone-responsive 13762NF rat mammary tumor in collagen gel culture.

Authors:  J E Richards; M Edery; R C Osborn; L N Larson; S Nandi
Journal:  J Natl Cancer Inst       Date:  1986-04       Impact factor: 13.506

6.  Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate.

Authors:  E Kordon; C Lanari; R Meiss; P Elizalde; E Charreau; C Dosne Pasqualini
Journal:  Breast Cancer Res Treat       Date:  1990-11       Impact factor: 4.872

7.  Improved technique for short-term culture and cytogenetic analysis of human breast cancer.

Authors:  N Pandis; S Heim; G Bardi; J Limon; N Mandahl; F Mitelman
Journal:  Genes Chromosomes Cancer       Date:  1992-07       Impact factor: 5.006

Review 8.  Sex steroids and growth factors in mammary cancer.

Authors:  B van der Burg
Journal:  Acta Endocrinol (Copenh)       Date:  1991

9.  Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells.

Authors:  S Bardon; F Vignon; P Montcourrier; H Rochefort
Journal:  Cancer Res       Date:  1987-03-01       Impact factor: 12.701

10.  Medroxyprogesterone acetate enhances spontaneous mammary tumorigenesis and uterine adenomyosis in mice.

Authors:  H Nagasawa; M Aoki; N Sakagami; M Ishida
Journal:  Breast Cancer Res Treat       Date:  1988-09       Impact factor: 4.872

View more
  8 in total

1.  Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.

Authors:  Cecilia Proietti; Mariana Salatino; Cinthia Rosemblit; Romina Carnevale; Adalí Pecci; Alberto R Kornblihtt; Alfredo A Molinolo; Isabel Frahm; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

2.  Inoculated mammary carcinoma-associated fibroblasts: contribution to hormone independent tumor growth.

Authors:  Victoria T Fabris; Ana Sahores; Silvia I Vanzulli; Lucas Colombo; Alfredo A Molinolo; Claudia Lanari; Caroline A Lamb
Journal:  BMC Cancer       Date:  2010-06-16       Impact factor: 4.430

3.  Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth.

Authors:  Cecilia J Proietti; Cinthia Rosemblit; Wendy Beguelin; Martín A Rivas; María Celeste Díaz Flaqué; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

4.  Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.

Authors:  Leticia Labriola; Mariana Salatino; Cecilia J Proietti; Adalí Pecci; Omar A Coso; Alberto R Kornblihtt; Eduardo H Charreau; Patricia V Elizalde
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

5.  A novel endocrine-disrupting agent in corn with mitogenic activity in human breast and prostatic cancer cells.

Authors:  Barry Markaverich; Shaila Mani; Mary Ann Alejandro; Andrea Mitchell; David Markaverich; Trellis Brown; Claudia Velez-Trippe; Chris Murchison; Bert O'Malley; Robert Faith
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

6.  Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice.

Authors:  Caroline A Lamb; Luisa A Helguero; Sebastián Giulianelli; Rocío Soldati; Silvia I Vanzulli; Alfredo Molinolo; Claudia Lanari
Journal:  Breast Cancer Res       Date:  2005-11-09       Impact factor: 6.466

7.  Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy.

Authors:  Alejandro C Curino; Lars H Engelholm; Susan S Yamada; Kenn Holmbeck; Leif R Lund; Alfredo A Molinolo; Niels Behrendt; Boye Schnack Nielsen; Thomas H Bugge
Journal:  J Cell Biol       Date:  2005-06-20       Impact factor: 10.539

8.  Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment.

Authors:  Guadalupe Montero Girard; Silvia I Vanzulli; Juan Pablo Cerliani; María Cecilia Bottino; Julieta Bolado; Jorge Vela; Damasia Becu-Villalobos; Fernando Benavides; Silvio Gutkind; Vyomesh Patel; Alfredo Molinolo; Claudia Lanari
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.